NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

AptarGroup director Giovanna Kampouri Monnas sells shares worth over $277k

Published 08/14/2024, 02:08 PM
ATR
-

In a recent transaction, Giovanna Kampouri Monnas, a director at AptarGroup, Inc. (NYSE:ATR), sold 1,922 shares of the company's common stock, generating over $277,000. The sale occurred on August 13, with the weighted average price per share being $144.4342. The transactions took place at prices ranging from $144.2800 to $144.5100.

Following the sale, Kampouri Monnas's ownership in AptarGroup decreased, leaving her with a total of 8,839 shares held directly. The sale was made public through a Form 4 filing with the Securities and Exchange Commission, which was dated August 14.

AptarGroup, Inc., headquartered in Crystal Lake, Illinois, is known for its diverse range of dispensing systems and packaging solutions, serving the pharmaceutical, beauty, home, and food and beverage sectors. The company's shares are traded on the New York Stock Exchange under the ticker symbol ATR.

Investors often monitor the buying and selling activities of a company's directors and executives as they may provide insights into the company's financial health and future prospects. However, such transactions can occur for various personal or financial reasons and do not always indicate a change in the company's outlook.

The detailed transactions and the subsequent ownership information are available to the public and can be requested from the SEC staff, the issuer, or a security holder of the issuer, as per the undertakings in the Form 4 filing.

In other recent news, Aptar has reported a robust growth in its second quarter of 2024, with a 3% increase in core sales and a 12% rise in adjusted earnings per share (EPS). The company's impressive performance is largely attributed to the high demand for its proprietary pharma drug delivery systems and improving margins. Aptar's pharma segment saw a 7% increase in core sales, while the beauty segment experienced a decline due to weaker sales in Europe.

On the financial front, Aptar's Q2 capital expenditures were approximately $68 million, predominantly allocated to the Pharma segment. The company anticipates this growth to continue into the third quarter, projecting an adjusted EPS between $1.38 and $1.46 per share.

Despite the strong performance, Aptar encountered some challenges, including higher corporate expenses and a decrease in the beauty segment's core sales due to lower demand in Europe. However, the company maintains a robust balance sheet, with a leverage ratio of approximately 1.3, which is expected to support ongoing investments and strategic opportunities. The company also expressed confidence in the continuation of earnings growth, with no significant changes in the competitive landscape anticipated.

InvestingPro Insights

Amid the recent sale of shares by director Giovanna Kampouri Monnas, AptarGroup, Inc. (NYSE:ATR) continues to display a stable financial outlook according to the latest metrics. With a market capitalization of approximately $9.55 billion and a Price/Earnings (P/E) ratio of 29.63, the company stands out in its industry. The adjusted P/E ratio for the last twelve months as of Q2 2024 is slightly lower at 26.82, indicating a more favorable valuation when considering the company's earnings over the past year.

Investors tracking the company's performance will note that AptarGroup has maintained a consistent revenue growth, with a 4.96% increase over the last twelve months as of Q2 2024. This steady growth is complemented by a solid gross profit margin of 36.94%, showcasing the company's effectiveness in managing its cost of goods sold and maintaining profitability.

An InvestingPro Tip worth noting is that AptarGroup has a commendable track record of raising its dividend, with 32 consecutive years of consistent payouts. This reflects the company's commitment to returning value to shareholders and its confidence in sustained financial health. Additionally, analysts are optimistic about the company's future, having revised their earnings upwards for the upcoming period. This could signal a positive outlook for the company's financial performance moving forward.

For investors seeking more in-depth analysis, there are additional InvestingPro Tips available on the company's profile at https://www.investing.com/pro/ATR. These tips provide valuable insights that can help investors make informed decisions about their investments in AptarGroup.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.